Amydis Funding & Investors
Los Angeles, CA
Amydis is a privately-held pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins.
amydis.comTotal Amount Raised: $19,585,724
Amydis Funding Rounds
Grant
$3,400,000
Grant Investors
National Institutes of Health (NIH)Series Unknown
$5,999,991
Grant
$1,500,000
Grant Investors
The Michael J. Fox Foundation for Parkinson's ResearchSeries Unknown
$5,685,732
Grant
$3,000,000
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)
Funding info provided by Diffbot.